JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

Neurogenic continence. Part 3: Bowel management strategies.

Neurogenic bowel dysfunction has a significant impact on quality of life of individuals with chronic neurological injuries and diseases, and management of this problem presents many challenges for both patients and healthcare professionals. These challenges include the limited evidence available to assist with the development of a satisfactory bowel management programme for individuals, and the small range of available options where conservative approaches are unsuccessful. This is the third article in a series of three on neurogenic bladder and bowel dysfunction. The prevalence and pathophysiology of these conditions, along with psychosocial impact they have on patients' quality of life, were discussed in part one, and part two discussed management options in neurogenic bladder. This article examines conservative care in neurogenic bowel management, the other options and the evidence to support them in this client group.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app